Literature DB >> 18177597

Psoriatic arthritis epidemiology.

Arathi R Setty1, Hyon K Choi.   

Abstract

Recent studies have added to our knowledge of the epidemiology of psoriatic arthritis (PsA) across various populations. Absence of a standard case definition and the relative rarity of PsA may have contributed to the paucity of available data to date. Reported prevalence estimates appear to vary more than incidence estimates. Prevalence estimates may vary as a result of differences in genetic factors, exposure to environmental factors, and study methods. Although prevalence data among different subgroups and extrapolation from clinical and laboratory data allow some inferences about the role of various potential risk factors for PsA, only one study has investigated them specifically. Overall, quality of life in PsA appears similar to that in rheumatoid arthritis, whereas available data on the mortality impact of PsA are conflicting, preventing a unified conclusion. This review summarizes recent data on PsA epidemiology.

Entities:  

Mesh:

Year:  2007        PMID: 18177597     DOI: 10.1007/s11926-007-0073-3

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  34 in total

1.  Immunogenetic profile of patients with psoriatic arthritis varies according to the age at onset of psoriasis.

Authors:  P Rahman; C T Schentag; D D Gladman
Journal:  Arthritis Rheum       Date:  1999-04

2.  Seronegative spondyloarthropathies in Greece: a population-based study of prevalence, clinical pattern, and management. The ESORDIG study.

Authors:  P Trontzas; A Andrianakos; S Miyakis; K Pantelidou; E Vafiadou; V Garantziotou; C Voudouris
Journal:  Clin Rheumatol       Date:  2005-04-29       Impact factor: 2.980

3.  A comparative evaluation of quality of life and life satisfaction in patients with psoriatic and rheumatoid arthritis.

Authors:  Pinar Borman; Guneş Gur Toy; Seçil Babaoğlu; Hatice Bodur; Deniz Ciliz; Nuran Alli
Journal:  Clin Rheumatol       Date:  2006-04-19       Impact factor: 2.980

4.  Incidence of psoriatic arthritis in Finland.

Authors:  O Kaipiainen-Seppänen
Journal:  Br J Rheumatol       Date:  1996-12

5.  The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991.

Authors:  M Shbeeb; K M Uramoto; L E Gibson; W M O'Fallon; S E Gabriel
Journal:  J Rheumatol       Date:  2000-05       Impact factor: 4.666

6.  Psoriatic arthritis and human immunodeficiency virus infection in Zambia.

Authors:  P Njobvu; P McGill
Journal:  J Rheumatol       Date:  2000-07       Impact factor: 4.666

7.  Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study.

Authors:  Hugh Zachariae; Robert Zachariae; Kirsti Blomqvist; Steingrimur Davidsson; Lars Molin; Cato Mørk; Bardur Sigurgeirsson
Journal:  Acta Derm Venereol       Date:  2002       Impact factor: 4.437

8.  Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death.

Authors:  D D Gladman; V T Farewell; K Wong; J Husted
Journal:  Arthritis Rheum       Date:  1998-06

9.  Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease.

Authors:  S M Jones; J B Armas; M G Cohen; C R Lovell; G Evison; N J McHugh
Journal:  Br J Rheumatol       Date:  1994-09

Review 10.  Epidemiology of psoriasis.

Authors:  Luigi Naldi
Journal:  Curr Drug Targets Inflamm Allergy       Date:  2004-06
View more
  7 in total

1.  Validity of psoriatic arthritis and capture of disease modifying antirheumatic drugs in the health improvement network.

Authors:  Alexis Ogdie; Sara Alehashemi; Thorvardur Jon Love; Yihui Jiang; Kevin Haynes; Sean Hennessy; Hyon Choi; Joel M Gelfand
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-07-05       Impact factor: 2.890

Review 2.  The Duality of Economic Issues With Medication Non-adherence in Patients With Inflammatory Arthritis.

Authors:  Natasha K J Campbell; Khalid Saadeldin; Mary A De Vera
Journal:  Curr Rheumatol Rep       Date:  2017-09-18       Impact factor: 4.592

3.  [Screening and early diagnosis of psoriasis arthritis].

Authors:  P Härle
Journal:  Z Rheumatol       Date:  2013-10       Impact factor: 1.372

4.  Prevalence and treatment patterns of psoriatic arthritis in the UK.

Authors:  Alexis Ogdie; Sinéad Langan; Thorvardur Love; Kevin Haynes; Daniel Shin; Nicole Seminara; Nehal N Mehta; Andrea Troxel; Hyon Choi; Joel M Gelfand
Journal:  Rheumatology (Oxford)       Date:  2012-12-07       Impact factor: 7.580

5.  HLA-Cw*06 class I region rather than MICA is associated with psoriatic arthritis in Czech population.

Authors:  Markéta Fojtíková; Jirí Stolfa; Peter Novota; Pavlína Cejková; Ctibor Dostál; Marie Cerná
Journal:  Rheumatol Int       Date:  2009-01-28       Impact factor: 2.631

6.  Time trends in epidemiology and characteristics of psoriatic arthritis over 3 decades: a population-based study.

Authors:  Floranne C Wilson; Murat Icen; Cynthia S Crowson; Marian T McEvoy; Sherine E Gabriel; Hilal Maradit Kremers
Journal:  J Rheumatol       Date:  2009-01-22       Impact factor: 4.666

Review 7.  Treatment recommendations for psoriatic arthritis.

Authors:  C T Ritchlin; A Kavanaugh; D D Gladman; P J Mease; P Helliwell; W-H Boehncke; K de Vlam; D Fiorentino; O Fitzgerald; A B Gottlieb; N J McHugh; P Nash; A A Qureshi; E R Soriano; W J Taylor
Journal:  Ann Rheum Dis       Date:  2008-10-24       Impact factor: 19.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.